Department of Pathology, Duke University Medical Center Box 3712, Duke Hospital South, Durham, NC 27710, USA.
Hum Pathol. 2012 Nov;43(11):2001-11. doi: 10.1016/j.humpath.2012.02.009. Epub 2012 May 18.
Dutcher bodies have been described in lymphoid neoplasms with plasmacytic differentiation, including plasma cell myeloma, lymphoplasmacytic lymphoma, and marginal zone lymphoma. We report a pathologic study of 3 cases of follicular lymphoma with extensive Dutcher body formation in comparison with lymphoplasmacytic lymphoma and marginal zone lymphoma. Of 3 cases, 1 showed a follicular growth pattern, whereas the other 2 cases demonstrated only a vague nodular appearance highlighted by immunohistochemical analysis. Cells containing Dutcher bodies were counted at 25, 90, or 110 per high-power field in each case, respectively. In 2 cases, cells with Dutcher bodies were clustered in an intrafollicular distribution, a possible histopathologic clue for follicular lymphoma. Immunoglobulin M κ was identified as the component of Dutcher bodies in all 3 cases, implying a possible molecular basis for the formation of Dutcher bodies in B-cell lymphomas. All 3 cases had cytogenetic changes supporting the diagnosis of follicular lymphoma, including dual rearrangement of BCL2 and BCL6, rearrangement of BCL2 with trisomy 3 (BCL6), and isolated BCL6 rearrangement. We emphasize immunohistochemical analyses with anti-κ/λ and anti-immunoglobulin heavy-chain isotypes to characterize Dutcher bodies and document clonality in addition to the routine lymphoma workup and indicated cytogenetic studies in B-cell lymphomas with prominent Dutcher bodies.
杜彻体曾在具有浆细胞分化的淋巴肿瘤中被描述过,包括浆细胞瘤、淋巴浆细胞淋巴瘤和边缘区淋巴瘤。我们报道了 3 例滤泡性淋巴瘤的病理研究,这些病例中有广泛的杜彻体形成,与淋巴浆细胞淋巴瘤和边缘区淋巴瘤进行了比较。这 3 例中,有 1 例显示滤泡生长模式,而另外 2 例仅表现为免疫组织化学分析突出的模糊结节外观。在每个病例中,分别计数了 25、90 或 110 个高倍视野中含有杜彻体的细胞。在 2 例中,含有杜彻体的细胞呈滤泡内聚集分布,这可能是滤泡性淋巴瘤的组织病理学线索。在所有 3 例中,均鉴定出杜彻体的免疫球蛋白 M κ 成分,这暗示了 B 细胞淋巴瘤中杜彻体形成的可能分子基础。所有 3 例均有细胞遗传学改变支持滤泡性淋巴瘤的诊断,包括 BCL2 和 BCL6 的双重重排、BCL2 与三体 3 的重排(BCL6)以及孤立的 BCL6 重排。我们强调用抗 κ/λ 和抗免疫球蛋白重链同种型进行免疫组织化学分析,以除了常规淋巴瘤检查和指示性细胞遗传学研究外,还可描述杜彻体并记录其克隆性,在具有明显杜彻体的 B 细胞淋巴瘤中。